AGP Executive Report
Last update: 10 hours agoVaccine Trial: Guinea-Bissau’s health minister says the country has not authorized a proposed hepatitis B study in 14,000 newborns, despite reports that a revised protocol received ethics approval. The trial would give half the babies the vaccine at birth and the rest at six weeks, the current national schedule. Researchers say they want to track broader health outcomes; critics warn delaying a proven vaccine could leave infants exposed to infection that can cause liver cancer and cirrhosis. The study’s status remains disputed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
